News
In its fourth quarter 2024 investor letter, Diamond Hill Mid Cap Strategy emphasized stocks such as ICON ... drug development for pharmaceutical clients. We believe the outlook over the long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback